BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19840458)

  • 21. MYC phosphorylation at novel regulatory regions suppresses transforming activity.
    Wasylishen AR; Chan-Seng-Yue M; Bros C; Dingar D; Tu WB; Kalkat M; Chan PK; Mullen PJ; Huang L; Meyer N; Raught B; Boutros PC; Penn LZ
    Cancer Res; 2013 Nov; 73(21):6504-15. PubMed ID: 24030976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
    Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
    J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
    Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
    Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy.
    Holien T; Misund K; Olsen OE; Baranowska KA; Buene G; Børset M; Waage A; Sundan A
    Oncotarget; 2015 Sep; 6(26):22698-705. PubMed ID: 26087190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas.
    Fujiwara K; Ikeda H; Yoshimoto T
    Clin Neuropathol; 1998; 17(1):19-26. PubMed ID: 9496536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.
    Song YF; Xu R; Zhang XH; Chen BB; Chen Q; Chen YM; Xie Y
    J Clin Pathol; 2006 Sep; 59(9):947-51. PubMed ID: 16489177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of PDCD5 in multiple myeloma and its relation with BCL-2].
    Jiang TB; Li X; Zhou J; Zhou Y; Yuan H; Xiang H; Yang GP; Lü HW; Xing XW; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):814-20. PubMed ID: 18812660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
    Zhou CH; Peng XD; Wu J; Zhang P; Zhao ZR; Wei DP; Zhang CJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):373-7. PubMed ID: 18575318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.
    Weinhold N; Meissner T; Johnson DC; Seckinger A; Moreaux J; Försti A; Chen B; Nickel J; Chubb D; Rawstron AC; Doughty C; Dahir NB; Begum DB; Young K; Walker BA; Hoffmann P; Nöthen MM; Davies FE; Klein B; Goldschmidt H; Morgan GJ; Houlston RS; Hose D; Hemminki K
    Haematologica; 2015 Mar; 100(3):e110-3. PubMed ID: 25480495
    [No Abstract]   [Full Text] [Related]  

  • 30. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
    Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
    Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gm6377 suppressed SP 2/0 xenograft tumor by down-regulating Myc transcription.
    Zhai B; Hou C; Xu R; Fang Y; Ma N; Xing C; Wang X; Xiao H; Chen G; Han G; Wang R
    Clin Transl Oncol; 2020 Sep; 22(9):1463-1471. PubMed ID: 31950438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups.
    Seidler HB; Utsuyama M; Nagaoka S; Takemura T; Kitagawa M; Hirokawa K
    Exp Mol Pathol; 2004 Jun; 76(3):224-33. PubMed ID: 15126105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation.
    Chappell SA; LeQuesne JP; Paulin FE; deSchoolmeester ML; Stoneley M; Soutar RL; Ralston SH; Helfrich MH; Willis AE
    Oncogene; 2000 Sep; 19(38):4437-40. PubMed ID: 10980620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma.
    Szabo AG; Gang AO; Pedersen MØ; Poulsen TS; Klausen TW; Nørgaard P
    Leuk Lymphoma; 2016 Nov; 57(11):2526-34. PubMed ID: 27243588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of c-myc-mRNA and c-MYC-protein during terminal neoplastic B-cell differentiation.
    Greil R; Loidl P; Fasching B; Huber H
    Curr Top Microbiol Immunol; 1992; 182():215-21. PubMed ID: 1490357
    [No Abstract]   [Full Text] [Related]  

  • 38. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
    Schlott T; Eiffert H; Bohne W; Landgrebe J; Brunner E; Spielbauer B; Knight B
    Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma?
    Saatci C; Caglayan AO; Kocyigit I; Akalin H; Kaynar LG; Altuntas F; Eser B; Demir M; Cetin M; Ozkul Y
    Hematology; 2010 Feb; 15(1):39-42. PubMed ID: 20132661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
    Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
    Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.